Skip to content

US · CON · MEDICAL - CARE FACILITIES

Concentra Group Holdings Parent, Inc. (CON) intrinsic value and stock valuation

$41.84as of 2026-11-21 · Mkt cap 3.94B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Concentra Group Holdings Parent, Inc. DCF and intrinsic value

InvestorsCraft values CON with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from CON’s statements →

Concentra Group Holdings Parent, Inc. Graham Number

Graham Number: $10.10d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Addison, TX 75001 concentra.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$2.16B
20212025
Net income
$172.8M
20212025
Free cash flow
$197.1M
20212025
Total equity
$420.4M
20222025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$2.16B$1.9B$1.84B$1.72B$1.73B
Operating income$2.09B$304.8M$287.6M$258.2M$270.3M
Net income$172.8M$166.5M$180M$166.7M$208.9M
EPSd$1.35M$1.3M$1.42M$1.32M$1.65M
Operating cash flow$279.4M$274.7M$234.3M$274.3M$290.6M
Capital expenditure-$-82.33M-$-64.33M-$-69.34M-$-45.98M-$-46.79M
Free cash flow$197.1M$210.4M$165M$228.4M$243.9M
Total assets$3.04B$2.52B$2.49B$2.3B—
Total debt$2.1B$1.95B$905M$1.04B—
Net debt$2.02B$1.77B$873.6M$1B—
Total equity$420.4M$298.7M$1.18B$996.1M—
Cash and short-term investments$79.9M$183.3M$31.4M$37.7M—
Income statement
20252024202320222021
Revenue$2.16B$1.9B$1.84B$1.72B$1.73B
Cost of revenue$1.55B$1.37B$1.33B$1.32B$1.3B
Gross profit$613.1M$528M$512.4M$408.2M$428M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$203.3M$156.3M$152M$150M$157.7M
Other expenses-$-1.68B$66.9M$72.8M$0.00$0.00
Operating expenses-$-1.47B$223.2M$224.8M$150M$157.7M
Cost and expenses$75.8M$1.6B$1.55B$1.47B$1.46B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$109.3M$69.7M$114M$31.6M$31.9M
Depreciation and amortization$75.8M$67.2M$73.1M$73.7M$82.2M
Ebitda$408.9M$368.3M$360.2M$330.2M$389.6M
Operating income$2.09B$304.8M$287.6M$258.2M$270.3M
Total other income/expenses, net-$-1.86B-$-73.37M-$-45M-$-33.32M$5.3M
Income before tax$223.8M$231.4M$242.6M$224.9M$275.6M
Income tax expense$51M$59.5M$57.9M$52.7M$59.5M
Net income$172.8M$166.5M$180M$166.7M$208.9M
Weighted average shares outstanding$126.7M$128.1M$126.6M$126.6M$126.6M
Weighted average diluted shares outstanding$128.2M$128.1M$126.6M$126.6M$126.6M
Balance sheet
2025202420232022
Cash and short-term investments$79.9M$183.3M$31.4M$37.7M
Net receivables$257.9M$217.7M$216.2M$206.3M
Inventory$0.00$0.00$0.00$0.00
Total current assets$383.1M$437.2M$294.4M$284.6M
Property, plant and equipment, net$709M$633.5M$576.2M$533.9M
Goodwill and intangible assets$1.72B$1.44B$1.45B$1.47B
Long-term investments$0.00$0.00$0.00$0.00
Total non-current assets$2.66B$2.08B$2.19B$2.01B
Total assets$3.04B$2.52B$2.49B$2.3B
Accounts payable$21M$19.8M$20.4M$27.7M
Short-term debt$95.3M$85.5M$74.4M$73M
Deferred revenue$0.00$0.00$0.00$50K
Total current liabilities$337.3M$307.2M$274.6M$279.6M
Long-term debt$2.01B$1.87B$830.6M$966.7M
Deferred revenue, non-current$0.00$2.97M$0.00$0.00
Total non-current liabilities$2.28B$1.92B$1.04B$1.02B
Capital lease obligations$445.3M$475.3M$357.3M$404.1M
Total liabilities$2.62B$2.22B$1.31B$1.3B
Common stock$1.29M$1.28M$470.3M$464.7M
Retained earnings$146.5M$13.6M$685.3M$508.6M
Accumulated other comprehensive income (loss)-$-3.35M$0.00$0.00$0.00
Total equity$420.4M$298.7M$1.18B$996.1M
Total investments$0.00$0.00$0.00$0.00
Total debt$2.1B$1.95B$905M$1.04B
Net debt$2.02B$1.77B$873.6M$1B
Cash flow statement
20252024202320222021
Net income$172.8M$171.9M$184.7M$172.2M$216M
Depreciation and amortization$0.00$67.2M$73.1M$73.7M$82.2M
Stock-based compensation$0.00$2.33M$650K$2.14M$2.14M
Change in working capital$7.96M$30.2M-$-18.7M$33.9M-$-7.28M
Accounts receivable-$-11.14M-$-1.6M-$-10.26M-$-5.93M$12.5M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$18M$24.6M$0.00$0.00$0.00
Net cash provided by operating activities$279.4M$274.7M$234.3M$274.3M$290.6M
Investments in property, plant and equipment$0.00-$-64.33M-$-69.34M-$-45.98M-$-46.79M
Acquisitions, net$0.00-$-6.96M-$-6M-$-11.8M-$-20.1M
Net cash used for investing activities-$-414.86M-$-71.27M-$-75.31M-$-57.75M-$-61.8M
Common stock issued$0.00$511.2M$3.34M$3.34M$10.1M
Common stock repurchased-$-22.42M-$-15.4M-$-5.32M-$-29.05M$0.00
Dividends paid-$-32.08M-$-1.54B-$-6.13M$0.00$0.00
Net cash used for financing activities$32.1M-$-51.53M-$-165.29M-$-209.86M-$-342.59M
Net change in cash-$-103.36M$151.9M-$-6.28M$6.73M-$-113.75M
Cash at end of period$79.9M$183.3M$31.4M$37.7M$30.9M
Operating cash flow$279.4M$274.7M$234.3M$274.3M$290.6M
Capital expenditure-$-82.33M-$-64.33M-$-69.34M-$-45.98M-$-46.79M
Free cash flow$197.1M$210.4M$165M$228.4M$243.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Concentra Group Holdings Parent, Inc.

        Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.

        CEO
        William Keith Newton
        Employees
        13.13K
        Beta
        0.69

        Explore

        Frequently asked questions

        What is the intrinsic value of Concentra Group Holdings Parent, Inc. (CON)?

        Concentra Group Holdings Parent, Inc. (CON) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CON undervalued?

        CON trades at a price of $41.84 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.